What to Know About Veozah, the Pricey New FDA-Approved Drug for Hot Flashes
Doctors say it’s a good option for menopausal women who don’t want to use hormones or can’t use hormones.
The Food and Drug Administration has approved a new medication to treat hot flashes in menopausal women. Veozah is designed to reduce the risk of developing moderate to severe hot flashes. “Hot flashes as a result of menopause can be a serious physical burden on women and impact their quality of life,” Janet Maynard, M.D., M.H.S., director of the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, in the FDA’s Center for Drug Evaluation and Research, says in a. “The introduction of a new molecule to treat moderate to severe menopausal hot flashes will provide an additional safe and effective treatment option for women.
This is a new medication and it works in a different way than other treatments for menopausal symptoms. Here’s what you need to know about Veozah.At a basic level, Veozah is a medication that is used to control hot flashes in women going through menopause. If you want to get a little more technical, it’s a neurokinin 3 receptor antagonist.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Menopause hot flashes medication receives FDA approvalThe once-a-day pill from Astellas Pharma uses a new approach, targeting brain connections that help control body temperature to treat moderate-to-severe symptoms, which can include sweating, flushing and chill.
Weiterlesen »
Brain-based treatment for menopausal hot flushes approved by FDAInvestigations into the impact of menopause on the brain have yielded a new way to treat troublesome symptoms without hormones.
Weiterlesen »
1st-of-its-kind drug for severe hot flashes during menopause approved by FDAThe U.S. Food and Drug Administration approved a new pill for moderate to severe hot flashes.
Weiterlesen »
FDA approves first-of-its-kind drug to treat hot flashesThe FDA has approved a first-of-its-kind drug to treat moderate to severe hot flashes during menopause.
Weiterlesen »
New Pedestrian Bridge From Crystal City To DCA Approved By Arlington County BoardArlington County approved the location of a new pedestrian bridge to DCA. It will start from the Crystal City VRE station and cross above train tracks and the George Washington Memorial Parkway.
Weiterlesen »